CCJ
Big-money love letter
Hardman Johnston Global Advisors LLC didn’t just nibble on Cameco — it loaded the cart. The firm boosted its stake in the uranium name by 326.7% in Q4, ending with 84,790 shares worth about $7.76 million.
Why investors should care
When a fund triples down this hard, it’s usually not because it lost a bet in a casino and got bored. It’s a signal that institutional investors still see a story in Cameco: nuclear fuel demand, uranium pricing, and the whole “energy transition but make it reliable” theme.
The catch: this isn’t the whole story
The article also reminds you that Cameco just posted a strong quarter, with EPS of $0.36 versus $0.29 expected and revenue of $874.6 million against $782.1 million estimates. So the stock has a couple of things going for it: smart-money accumulation and earnings that didn’t faceplant.
Zooming out
There’s also plenty of Wall Street chatter around the name, with analysts sitting around a Moderate Buy consensus and a chunky average target of $150.40. In other words: Cameco still has fans, and they’re not exactly whispering.
Big picture: this is another sign the uranium trade still has legs — and institutional investors are voting with real money, not just hot takes.